Technology is now being deployed to different aspects of life to help make things easier. When it comes to health, there is a need for extra care because it involves the lives of people. If it makes health care delivery easier and it is safe, then it needs to be put to use. However, not before appropriate approvals by relevant authorities. According to recent reports, the U.S. Food and Drug Administration (FDA) approved an application to help with insulin delivery. This is the first app that is getting approval to help with insulin delivery.
The developer of the application, Tandem Diabetes Care, recently announced that its t:connect mobile app now has FDA clearance for use. Through the t:slim X2 insulin pump, the app can help users to control bolus insulin delivery.
In a press statement, Tandem CEO John Sheridan said
With this application, users of the t:slim X2 can activate the pump remotely. This permits very discrete handling of diabetics as the patients get their insulin doses. This application will be available on both Android and iOS. Thus, it doesn’t matter the platform that you belong to, you can have access to the app.
Insulin delivery app is a good advancement for diabetes control
Furthermore, the application can also help users to maintain their glucose level while eating by canceling or programming the insulin levels during mealtime. If you own a t:slim X2, you do not need to pay an extra fee for the pump. You will receive a software update for the pump for free. This makes it compatible with the t:support app.
According to Tandem Diabetes Care, as of 2020, it had no less than 200,000 customers. This shows its solutions are quite popular. With the official approval of the application, Tandem’s patronage will likely increase.
Diabetes is a chronic condition that requires proper management otherwise it can be fatal. Many refer to diabetes as a “silent killer” because the complications may not surface until it is late. According to the Centers for Disease Control and Prevention, for the second year in a row (2020 & 2021), the number of diabetes-related deaths exceeds 100,000.
